IT1212658B - Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale - Google Patents

Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale

Info

Publication number
IT1212658B
IT1212658B IT8267487A IT6748782A IT1212658B IT 1212658 B IT1212658 B IT 1212658B IT 8267487 A IT8267487 A IT 8267487A IT 6748782 A IT6748782 A IT 6748782A IT 1212658 B IT1212658 B IT 1212658B
Authority
IT
Italy
Prior art keywords
protein
soln
crude
mol
gel filtration
Prior art date
Application number
IT8267487A
Other languages
English (en)
Other versions
IT8267487A0 (it
Inventor
Katsuyuki Haranaka
Lloyd J Old
Elizabeth C Richards
Barbara Williamson
Original Assignee
Asahi Chemical Ind
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Ind, Dainippon Pharmaceutical Co filed Critical Asahi Chemical Ind
Priority to IT8267487A priority Critical patent/IT1212658B/it
Publication of IT8267487A0 publication Critical patent/IT8267487A0/it
Application granted granted Critical
Publication of IT1212658B publication Critical patent/IT1212658B/it

Links

Landscapes

  • Peptides Or Proteins (AREA)
IT8267487A 1982-04-13 1982-04-13 Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale IT1212658B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT8267487A IT1212658B (it) 1982-04-13 1982-04-13 Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8267487A IT1212658B (it) 1982-04-13 1982-04-13 Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale

Publications (2)

Publication Number Publication Date
IT8267487A0 IT8267487A0 (it) 1982-04-13
IT1212658B true IT1212658B (it) 1989-11-30

Family

ID=11302821

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8267487A IT1212658B (it) 1982-04-13 1982-04-13 Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale

Country Status (1)

Country Link
IT (1) IT1212658B (it)

Also Published As

Publication number Publication date
IT8267487A0 (it) 1982-04-13

Similar Documents

Publication Publication Date Title
DK382986A (da) Aktivering af makrofag tumoricid aktivitet med granulocytmakrofag kolonistimulationsfaktor
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
GB1356911A (en) Purification and fractionation of carcinoembryonic antigen
EP0911033A3 (en) Methods and compositions for the treatment of diseases with interferon while reducing side effects
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
IT8709354A0 (it) Siringa per iniezioni,in specie endovenose,realizzata per poteressere usata una sola volta,senza possibilita' di riaspirazione.
EP0242233A3 (en) Lymphokines for use in the treatment of infections
GB9224584D0 (en) Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
ES8507567A1 (es) Metodo para estabilizar un concentrado de gamma globulina
HK1006154A1 (en) Pharmaceutic composition based on diphoshonates for the treatment of the arthrosis
DE68926679D1 (de) Physiologisch aktives polypeptid, rekombinantes plasmid, rekombinante mikrobielle zellen, medizinisches präparat sowie verfahren zur gewinnung des gereinigten polypeptids
IL77101A (en) Method for purifying a human tnf produced by recombinant dna technique
JPS57140725A (en) Physiologically active substance having carcinostatic action
AU2855189A (en) Method of treating fibrotic disorders
TW259710B (it)
IT1212658B (it) Procedimento per la purificazione di una sostanza fisiologicamente attiva avente attivita antitumorale
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
AU7336687A (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
PT80214A (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
MY107071A (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
EP0219839A3 (de) Derivat des Interleukin-2, seine Herstellung und Verwendung
Meisel et al. Efficacy of ciprofloxacin in bacterial infections of the skin.
RU96102282A (ru) Способ терапии поллиноза
EP0154598A3 (en) Method and device for administering medicines or the like to aquatic animals, in particular fish
RU96102269A (ru) Способ терапии хронических тонзиллитов и фарингитов

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970429